Sleep Apnea Devices Market Size and Growth Outlook
The global Sleep Apnea Devices Market is positioned for substantial expansion over the next decade. The industry is projected to grow from US$ 6.47 Billion in 2024 to US$ 12.23 Billion by 2033, reflecting a strong CAGR of 7.32% between 2025 and 2033.
This growth is fueled by the rising prevalence of obstructive sleep apnea (OSA), increasing obesity rates, sedentary lifestyles, growing awareness of sleep-related disorders, and improved diagnostic infrastructure. Technological innovation—particularly in connected, portable, and patient-friendly devices—is also improving treatment adherence and driving sustained adoption.
The United States remains the dominant regional market. A 2024 study estimated that approximately 80.6 million Americans suffer from OSA, including 47.6 million men (59%) and 33 million women (41%). Strong insurance coverage for CPAP machines and accessories further supports market expansion.
Download Free Sample Report:https://www.renub.com/request-sample-page.php?gturl=sleep-apnea-devices-market-competitor-analysis-p.php
Leading Companies in the Sleep Apnea Devices Market
1. CareFusion Corporation
CareFusion Corporation
- Founded: 2009
- Headquarters: United States
CareFusion was established as a spin-off from Cardinal Health with a focus on improving medication safety and reducing healthcare-associated infections. Its portfolio included ventilators, infusion pumps, surgical tools, and automated dispensing systems.
In March 2015, CareFusion was acquired by Becton, Dickinson and Company for US$ 12.2 billion, integrating its respiratory and infusion solutions into BD’s broader healthcare portfolio.
The company played a foundational role in respiratory care innovation, strengthening infrastructure for hospital-based sleep and ventilatory support systems.
2. SomnoMed
SomnoMed
- Established: 2004
- Headquarters: Australia
SomnoMed is a global leader in oral appliance therapy for obstructive sleep apnea. Its SomnoDent® product range provides custom-fitted oral devices designed as an alternative to CPAP therapy.
Key strengths include patient comfort optimization and innovation such as the patented b-flex Comfort Liner®. The company focuses heavily on compliance-driven therapy solutions, offering personalized alternatives for patients intolerant to CPAP machines.
3. Koninklijke Philips N.V.
Koninklijke Philips N.V.
- Founded: 1891
- Headquarters: Netherlands
Philips is a diversified health technology company with strong presence in sleep and respiratory care. Its offerings include CPAP and BiPAP devices, masks, connected monitoring systems, and sleep diagnostics.
Beyond sleep therapy, Philips operates in imaging systems (MRI, CT), monitoring equipment, and personal health devices. Its global distribution network across North America, Europe, and Asia strengthens its competitive position.
4. Nihon Kohden Corporation
Nihon Kohden Corporation
- Established: 1951
- Headquarters: Japan
Nihon Kohden designs and distributes medical electronic equipment, including patient monitoring systems, EEG devices, and respiratory care products.
The company serves hospitals, research centers, and home healthcare providers globally. Its expertise in neurodiagnostics and respiratory monitoring enhances its role in sleep disorder diagnosis and treatment support.
5. Natus Medical Incorporated
Natus Medical Incorporated
- Founded: 1987
- Headquarters: United States
Natus specializes in neurodiagnostic and sleep diagnostic solutions. Its product portfolio includes EEG systems, EMG tools, polysomnography (PSG) solutions, and home sleep testing devices.
The company plays a key role in diagnostic infrastructure, offering both in-lab and home-based sleep study solutions that enable early detection and management of OSA.
Sustainability Analysis in the Sleep Apnea Devices Market
Teleflex Incorporated
Teleflex Incorporated
Teleflex has structured its sustainability strategy around four pillars:
Planet & Environment
- Reduction of greenhouse gas emissions
- Waste and energy optimization
- Alignment with climate goals
People
- Employee health and safety
- Diversity and inclusion
Community & Sustainable Healthcare
- Access to care initiatives
- Product safety and quality programs
Ethics & Governance
- Compliance and risk management
- Transparent reporting
Climate Commitments
- Science Based Targets initiative (SBTi) validated climate goals
- Net-zero GHG emissions by 2050
- ~54.6% reduction in Scope 1 & 2 emissions by 2032
- ~32.5% reduction in Scope 3 emissions by 2032
- ~90% absolute emission reduction target by 2050
Reporting aligns with global sustainability disclosure standards.
SWOT Insights
BMC Medical Co. Ltd. – Strength Analysis
BMC Medical Co. Ltd.
Key Strength: Strong financial stability and low leverage.
- Healthy capital structure
- High shareholder equity relative to liabilities
- Reduced vulnerability to interest rate fluctuations
- Strong working capital management
This financial flexibility allows BMC Medical to invest in innovation and regional expansion without excessive reliance on debt financing.
BMC Medical Co. Ltd. – Opportunity Analysis
BMC Medical is well positioned to capitalize on increasing respiratory care demand in China and emerging Asia-Pacific markets.
Opportunities include:
- Expansion of oxygen therapy and CPAP products
- Development of portable, cost-effective devices
- Strengthening distribution in underserved regions
- Localization strategies aligned with affordability and regulatory needs
Cadwell Industries, Inc. – Strength Analysis
Cadwell Industries, Inc.
Cadwell’s strength lies in its integrated neurodiagnostic and sleep diagnostic portfolio.
Offerings include:
- EEG solutions
- EMG/NCS systems
- Intraoperative neuromonitoring
- Polysomnography
- Home sleep apnea testing (HSAT)
Its emphasis on usability, clinician support, and AI-based enhancements strengthens brand credibility and long-term customer retention.
Cadwell Industries, Inc. – Opportunity Analysis
Expansion into remote diagnostics and AI-driven analytics presents significant growth potential.
The company’s investment in home-based monitoring platforms supports remote video EEG and sleep diagnostics. Rising demand for ambulatory care aligns well with Cadwell’s strategic direction.
Cloud-based platforms, AI-assisted scoring, and workflow automation can significantly broaden its market reach.
Recent Developments
- In April 2025, Vivos Therapeutics, Inc. acquired The Sleep Center of Nevada for US$ 9 million, expanding access to FDA-approved oral appliance therapy.
- In March 2025, Fisher & Paykel Healthcare launched the F&P Nova Nasal mask in Australia and New Zealand.
- In January 2025, ResMed Inc. introduced the AirSense 11 CPAP machine in India with integrated remote monitoring capabilities.
Additional Key Market Participants
- Compumedics Limited
- Drive DeVilbiss Healthcare
- Braebon Medical Corporation
- Itamar Medical Ltd.
- Invacare Corporation
Company analysis typically includes:
- Corporate overview
- Executive leadership
- Product portfolio
- Mergers & acquisitions
- Sustainability initiatives
- Revenue performance
- SWOT analysis
Final Thoughts
The Sleep Apnea Devices Market is projected to nearly double by 2033, driven by rising OSA prevalence, digital innovation, home-based diagnostics, and improved reimbursement structures.
Companies that successfully integrate AI-driven analytics, remote monitoring, patient-centric design, and sustainability commitments will gain a competitive advantage in this rapidly evolving healthcare segment.
As awareness increases and diagnostic accessibility improves worldwide, the sleep apnea devices industry is positioned for sustained, innovation-led growth.
